Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Oncology Institute Equity Warrant Exp 15th Nov 2026 TOIIW

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including... see more

Recent & Breaking News (NDAQ:TOIIW)

The Oncology Institute to Participate at Upcoming Investor Conferences

GlobeNewswire February 27, 2024

Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model

GlobeNewswire February 20, 2024

WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio

GlobeNewswire January 25, 2024

The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California

GlobeNewswire December 4, 2023

The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

GlobeNewswire November 8, 2023

The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call

GlobeNewswire October 18, 2023

The Oncology Institute Names Jeremy Castle as Chief Operations Officer

GlobeNewswire October 11, 2023

The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit

GlobeNewswire September 26, 2023

The Oncology Institute Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire September 18, 2023

Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology

GlobeNewswire August 9, 2023

The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

GlobeNewswire August 8, 2023

The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations

GlobeNewswire July 31, 2023

The Oncology Institute Announces Second Quarter 2023 Earnings Release Date and Conference Call

GlobeNewswire July 18, 2023

The Oncology Institute Announces Leadership Transition

GlobeNewswire June 12, 2023

The Oncology Institute (TOI) and Massive Bio Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research

GlobeNewswire June 9, 2023

The Oncology Institute to Open Project Southland

GlobeNewswire June 7, 2023

The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting

GlobeNewswire May 31, 2023

The Oncology Institute to Participate at Upcoming Investor Conferences

GlobeNewswire May 31, 2023

The Oncology Institute Reports First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

GlobeNewswire May 10, 2023

TOI Patient is First Worldwide to be Treated with Promising Therapy for Metastatic Ovarian Cancer

GlobeNewswire May 2, 2023